Genetic Signatures Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ali Rossiter
Chief executive officer
AU$1.3m
Total compensation
| CEO salary percentage | 29.43% |
| CEO tenure | 1.2yrs |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Even With A 26% Surge, Cautious Investors Are Not Rewarding Genetic Signatures Limited's (ASX:GSS) Performance Completely
Nov 08
We Think Genetic Signatures (ASX:GSS) Can Afford To Drive Business Growth
Aug 25We Think Genetic Signatures (ASX:GSS) Can Afford To Drive Business Growth
May 08Genetic Signatures Limited (ASX:GSS) Might Not Be As Mispriced As It Looks After Plunging 30%
Apr 11Getting In Cheap On Genetic Signatures Limited (ASX:GSS) Might Be Difficult
Jun 14After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar
Mar 08A Look At The Fair Value Of Genetic Signatures Limited (ASX:GSS)
Nov 14Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected
Oct 10One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates
Jun 29Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Feb 28AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results
Feb 25What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?
Feb 07
What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?
Jan 17Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth
Dec 27Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business
Dec 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | AU$1m | AU$387k | -AU$20m |
Compensation vs Market: Ali's total compensation ($USD852.67K) is above average for companies of similar size in the Australian market ($USD296.98K).
Compensation vs Earnings: Insufficient data to compare Ali's compensation with company performance.
CEO
Ali Rossiter
Ms. Allison Rossiter, also known as Ali, serves as Chief Executive Officer at Genetic Signatures Limited from September 23, 2024. She has extensive healthcare experience, with a distinguished career at Roc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.2yrs | AU$1.31m | no data | |
| CFO, COO & Company Secretary | 2.4yrs | AU$383.55k | 0.0092% A$ 6.1k | |
| Executive Director of US Operations & Executive Director | 11.8yrs | AU$185.65k | 0.31% A$ 206.6k | |
| Founder & Chairman Emeritus | no data | no data | no data | |
| Chief Technology Officer | less than a year | no data | no data | |
| Global Head of People & Culture | 1.8yrs | no data | no data |
Experienced Management: GSS's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Director of US Operations & Executive Director | 11.8yrs | AU$185.65k | 0.31% A$ 206.6k | |
| Founder & Chairman Emeritus | no data | no data | no data | |
| Independent Non-Executive Director | 1.1yrs | AU$56.03k | no data | |
| Chairman of the Board | 3.5yrs | AU$153.77k | 0.0099% A$ 6.5k | |
| Independent Non-Executive Director | 1.1yrs | AU$56.03k | no data | |
| Non-Executive Director | 4.6yrs | AU$348.55k | no data |
Experienced Board: GSS's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 21:51 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genetic Signatures Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anubhav Saxena | Bell Potter |
| Thomas Wakim | Bell Potter |
| Dennis Hulme | Taylor Collison Limited |